Mini-Symposium: Newborn screening for inborn errors of metabolism - Clinical effectiveness

Journal of Inherited Metabolic Disease

Volumn 29, Issue 2-3, 2006, Pages 366-369

  Wilcken, Bridget ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EARLY INTERVENTION; HUMAN; INBORN ERROR OF METABOLISM; INTERMETHOD COMPARISON; NEWBORN; NEWBORN SCREENING; PHENYLKETONURIA; STANDARDIZATION; TANDEM MASS SPECTROMETRY; UNCERTAINTY;

CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED MEDICINE; HUMANS; INFANT, NEWBORN; METABOLISM, INBORN ERRORS; NEONATAL SCREENING; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC; PROGRAM EVALUATION; TANDEM MASS SPECTROMETRY;

EID: 33745075959     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-005-0254-z     Document Type: Article

References (18)

1. Alm J, Hagenfeldt L, Larsson A, Lundberg K (1984) Incidence of congenital hypothyroidism: Retrospective study of neonatal laboratory screening versus clinical symptoms as indicators leading to diagnosis. BMJ Clin Res Ed 289(6453): 1171-1175.
2. Campbell E, Ross LF (2003) Parental attitudes regarding newborn screening of PKU and DMD. Am J Med Genet Pt A 120(2): 209-214.
3. Chatfield S, Owen G, Ryley HC, et al (1991) Neonatal screening for cystic fibrosis in Wales and the West Midlands: Clinical assessment after five years of screening. Arch Dis Child 66: 29-33.
4. Drumm ML, Konstan MW, Schluchter MD, et al (2005) Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 353(14): 1443-1453.
5. Escolar ML, Poe MD, Provenzale JM, et al (2005) Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med 352(20): 2069-2081.
6. Farrell PM, Mischler EH (1992) Newborn screening for cystic fibrosis. The Cystic Fibrosis Neonatal Screening Study Group. Adv Pediatr 39: 35-70.
7. Goddard P (2004) Newborn screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) in the UK. J Fam Health Care 14(4): 90-92.
8. Guidelines of the German Ministry of Health and Social Affaires (2004) 21st December 2004 Internet references. Retreived from: http://www.aerzteblatt.de/v4/archiv/artikel.asp?id=46488 28/10/2005.
9. Guthrie R, Susi A (1963) A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 32: 338-343.
10. Komrower GM, Sardharwalla IB, Coutts JM, Ingham D (1979) Management of maternal phenylketonuria: An emerging clinical problem. Br Med J 1(6175):1383-1387.
11. Maternal and Child Health Bureau (2005) Internet references. Retrieved from: http://mchb.hrsa.gov/screening/ 26/10/2005.
12. Menkes JH, Holtzman NA (1970) Phenylalaninemia or classical phenylketonuria. Neuropadiatrie 2(1): 121-122.
13. Pourfarzam M, Morris A, Appleton M, Craft A, Bartlett K (2001) Neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency. Lancet 358: 1063-1064.
14. Scriver CR, Levy HL (1983) Histidinaemia. Part I: Reconciling retrospective and prospective findings. J Inherit Metab Dis 6(2): 51-53.
15. Tada K, Yoshida T, Mochizuki K, Konno T, Nakagawa H (1970) Two siblings of hyperphenylalaninemia: Suggestion to a genetic variant of phenylketonuria. Tohoku J Exp Med 100(3): 249-253.
16. Wall Street Journal (2005) Internet references. Retrieved from http://www.post-gazette.com/pg/05139/507278.stm 28/10/2005.
17. Wilcken B, Wiley V, Hammond J, Carpenter K (2003) Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med 348: 2304-2312.
18. Woods WG, Gao RN, Shuster JJ, et al (2002) Screening of infants and mortality due to neuroblastoma. N Engl J Med 346: 1041-1046.